Abstract
The effects of HIV on brain metabolites and cognitive function are not well understood. Sixteen HIV+youths (15 vertical, 1 transfusion transmissions) receiving combination antiretroviral therapy and 14 age-matched HIV- youths (13–25 years of age) were evaluated with brain two-dimensional (2D) magnetic resonance spectroscopy (MRS) at 3 Tesla (T) and a neuropsychological battery that assessed three cognitive domains (attention/processing speed, psychomotor ability, and executive function). The relationship between brain metabolite ratios and cognitive performance was explored. Compared to HIV- controls, HIV+ subjects had higher sycllo-inositol (Scy)/total creatine (tCr) (+32%, p = 0.016) and higher Scy/total choline (tCho) (+31%, p = 0.018) on 2D-MRS in the right frontal lobe. HIV+ subjects also had higher glutamate (Glu)/tCr (+13%, p = 0.022) and higher Glu/tCho (+15%, p = 0.048) than controls. HIV+ subjects demonstrated poorer attention/processing speed (p = 0.011, d = 1.03) but similar psychomotor and executive function compared to HIV- controls. The attention/processing score also correlated negatively with the ratio of N-acetylaspartate (NAA) to tCr on 2D-MRS (r = −0.75, p = 0.0019) in the HIV- controls, but not in the HIV+ subjects (Fisher’s r-z transformation, p < 0.05). Our results suggest that attention/processing speed is impacted by early HIV infection and is associated with right hemisphere NAA/tCr. Scy and Glu ratios are also potential markers of brain health in chronic, lifelong HIV infection in perinatally infected youths receiving antiretroviral therapy.
Similar content being viewed by others
References
Banakar S, Thomas MA, Deveikis A, Watzl JQY, Hayes J, Keller MA (2008) Two-dimensional 1H-MRS spectroscopy of the brain in human immunodeficiency virus (HIV)-infected children. J Magn Reson Imaging 27:710–717
Becker LA (2011) Effect Size. http://www.uccs.edu/faculty/becker http://web.uccs.edu/lbecker/Psy590/es.htm..
Bisiacchi PS, Suppiej A, Laverda A (2000) Neuropsychological evaluation of neurologically asymptomatic HIV-infected children. Brain Cogn 43(1–3):49–52
Blanchette N, Smith ML, King S, Fernandes-Penney A, Read S (2002) Cognitive development in school-age children with vertically transmitted HIV infection. Dev Neuropsychol 21(3):223–241
Bottomley PA (1987) Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci 508:333–348
Cavassila S, Deval S, Huegen C, van Ormondt D, Graveron-Demilly D (2001) Cramer-Rao bounds: an evaluation tool for quantitation. NMR Biomed 14:278–283
Chang L, Ernst T, Witt MD, Ames N, Gaiefsky M, Miller E (2002) Relationships among cerebral metabolites, cognitive function and viral loads in antiretroviral-naïve HIV patients. NeuroImage 17(3):1638–1648
Conners CK, Staff MHS (2000) Conners’ continuous performance test II (CPT II) computer program for windows™ technical guide and software manual. Multi-Health Systems, Inc., North Tonawanda, NY
Chong WK, Sweeney B, Wilkinson ID, Paley M, Hall-Craggs MA, Kendall BE, Shepard JK, Beecham M, Miller RF, Weller IVD, Newman SP, Harrison MJG (1993) Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic and MR imaging findings. Radiology 188:119–124
Delis DC, Kaplan E, Kramer J (2001) Delis kaplan executive function system. The Psychological Corporation, San Antonio
Erdmann N, Tian C, Huang Y, Zhao J, Herek S, Curthoys N, Zheng J (2009) In vitro glutaminase regulation and mechanisms of glutamate generation in HIV-1-infected macrophage. J Neurochem 109(2):551–561
Ernst T, Jiang CS, Nakama H, Buchthal S, Chang L (2010) Lower brain glutamate is associated with cognitive deficits in HIV patients: a new mechanism for HIV-associated neurocognitive disorder. J Magn Reson Imaging 32(5):1045–1053
Frias-Martinez F, Rajakumar N, Lis XS, Singhal A, Banakar S, Lipnick S, Verma G, Ramadan S, Kumar A, Thomas MA (2008) ProFit-based quantitation of cerebral metabolites using 2D-L-COSY at 3T. International Society of Magnetic Resonance in Medicine (ISMRM) Conference, Toronto, Canada, #691.
Gabis L, Belman A, Huang W, Milazzo M, Nachman S (2006) Clinical and imaging study of human immunodefriciency virus-1-infected youth receiving highly active antiretroviral therapy: pilot study using magnetic resonance spectroscopy. J Child Neurology 21:486–490
Griffith HR, den Hollander JA, Stewart CC, Evanochko WT, Buchthal SD, Harrell LE, Zamrini EY, Brockington JC, Marson DC (2007) Elevated brain scyllo-inositol concentrations in patients with Alzheimer’s disease. NMR Biomed 20(8):709–716
Gruetter R (1993) Automatic, localized in vivo adjustment of all first- and second-order shim coils. Magn Reson Med 29(6):804–811
Hassel B, Dingledine R (2006) In: Siegel GJ, Albers RW, Brady ST, Price DL (eds.) Basic neurochemistry, molecular, cellular, and medical aspects, 7 Edn, Chapter 15, Glutamate. 267–290. Academic Press, Elsevier.
Hinkin CK, Castellon SA, van Gorp WG, Buckingham SL et al (1998) Neuropsychological features of HIV disease. In: van Gorp WG, Buckingham SL (eds) A mental health practitioner's guide to the neuropsychiatric complications of HIV/AIDS. Oxford University Press, New York, pp 1–41
Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, CHARTER Group; HNRC Group (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17(1):3–16
Heaton RK, Grant I, Butters N, White DA, Kirson D, Atkinson JH, McCutchan JA, Taylor MJ, Kelly MD, Ellis RJ, Wolfson T, Velin R, Marcotte TD, Hesselink JR, Jernigan TL, Chandler J, Wallace M, Abramson I, Group HNRC (1995) The HNRC 500–neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc 1(3):231–251
Kaiser LG, Schuff N, Cashdollar N, Weiner MW (2005) Scyllo-inositol in normal aging human brain: 1H magnetic resonance spectroscopy study at 4 Tesla. NMR Biomed 18(1):51–55
Keller MA, Venkatraman TN, Thomas A, Deveikis A, LoPresti C, Hayes J, Berman N, Walot I, Padilla S, Johnston-Jones J, Ernst T, Chang L (2004) Altered neurometabolite development in HIV-infected children, Correlation with neuropsychological tests. Neurology 62:1810–1817
Keller MA, Venkatraman TN, Thomas MA, Deveikis A, Lopresti C, Hayes J, Berman N, Walot I, Ernst T, Chang L (2006) Cerebral metabolites in HIV-infected children followed for 10 Months with 1H-MRS. Neurology 66:874–879
Koekkoek S, de Sonneville LM, Wolfs TF, Licht R, Geelen SP (2008) Neurocognitive function profile in HIV-infected school-age children. Eur J Paediatr Neurol 12(4):290–297
Lange T, Schulte RF, Boesiger P (2008) Quantitative J-resolved prostate spectroscopy using two-dimensional prior-knowledge fitting. Magn Reson Med 59(5):966–972
Laubenberger J, Haussinger D, Bayer S, Thielemann S, Schneider B, Mundinger A, Hennig J, Langer M (1996) HIV-related metabolic abnormalities in the brain: Depiction with proton MR spectroscopy with short echo times. Radiology 199:805–810
Lopez-Villegas D, Lenkinski RE, Frank I (1997) Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy. Proc Natl Acad Sci U S A 94(18):9854–9859
Lu D, Pavlakis SG, Frank Y, Bakshi S, Pahwa S, Gould RJ, Sison C, Hsu C, Lesser M, Hoberman M, Barnett T, Hyman RA (1996) Proton MR spectroscopy of the basal ganglia in healthy children and children with AIDS. Radiology 199:423–428
Martin SC, Wolters PL, Toledo-Tamula MA, Zeichner SL, Hazra R, Civitello L (2006) Cognitive functioning in school-aged children with vertically acquired HIV infection being treated with highly active antiretroviral therapy (HAART). Dev Neuropsychol 30(2):633–657
Meyerhoff D, Fein G, Weiner M (1996) Elevated scyllo-inositol in adult human brain. Proceedings ISMRM, 4th Scientific Meeting, New York, p 954.
Miller EN, Selnes OA, McArthur JC, Satz P, Becker JT, Cohen BA, Sheridan K, Machado AM, Van Gorp WG, Visscher B (1990) Neuropsychological performance in HIV-1 infected homosexual men: the Multicenter AIDS Cohort Study (MACS). Neurology 40:197–203
Mohamed MA, Barker PB, Skolasky RL, Selnes OA, Moxley RT, Pomper MG, Sacktor NC (2010) Brain metabolism and cognitive impairment in HIV infection: a 3-T magnetic resonance spectroscopy study. Magn Reson Imaging 28(9):1251–1257
Möller HE, Vermathen P, Lentschig MG, Schuierer G, Schwarz S, Wiedermann D, Evers S, Husstedt IW (1999) Metabolic characterization of AIDS dementia complex by spectroscopic imaging. J Magn Reson Imaging 9(1):10–18
Nagarajan R, Sarma MK, Thames AD, Castellon SA, Hinkin CH, Thomas MA (2012) 2D MR spectroscopy combined with prior-knowledge fitting is sensitive to HCV-associated cerebral metabolic abnormalities. Int J Hepatol 2012:179365
Ogg RJ, Kingsley PB, Taylor JS (1994) WET, a T1- and B1-insensitive water-suppression method for in vivo localized 1H NMR spectroscopy. J Magn Reson B 104(1):1–10
Patel K, Ming X, Williams PL, Robertson KR, Oleske JM, Seage GR III, International Maternal Pediatric Adolescent AIDS Clinical Trials 219/219C Study Team (2009) Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents. AIDS 23(14):1893–1901
Pavlakis SG, Lu D, Frank Y, Bakshi S, Pahwa S, Barnett TA, Porricolo ME, Gould RJ, Nozyce ML, Hyman RA (1995) Magnetic resonance spectroscopy in childhood AIDS encephalopathy. Pediatr Neurol 12:277–282
Pavlakis SG, Lu D, Frank Y, Wiznia A, Eidelberg D, Barnett T, Hyman RA (1998) Brain lactate and N-acetylaspartate in pediatric AIDS encephalopathy. Am J Neuroradiol 19(2):383–385
Sailasuta N, Shriner K, Ross B (2009) Evidence of reduced glutamate in the frontal lobe of HIV-seropositive patients. NMR Biomed 22:326–331
Salvan A-M, Lamoureux S, Michel G, Confort-Gourny S, Cozzone PJ, Vion-Dury J (1998) Localized proton magnetic resonance spectroscopy of the brain in children infected with human immunodeficiency virus with and without encephalopathy. Pediatr Res 44:755–762
Seaquist ER, Gruetter R (1998) Identification of a high concentration of scyllo-inositol in the brain of a healthy human subject using 1H- and 13C-NMR. Magn Reson Med 39(2):313–316
Selnes OA, Galai N, Bacellar H, Miller EN, Becker JT, Wesch J, Van Gorp W, McArthur JC (1995) Cognitive performance after progression to AIDS: a longitudinal study from the Multicenter AIDS Cohort Study. Neurology 45(2):267–275
Smith R, Chernoff M, Williams PL, Malee KM, Sirois PA, Kammerer B, Wilkins M, Nichols S, Mellins C, Usitalo A, Garvie P, Rutstein R, for the Pediatric HIV/AIDS Cohort Study (PHACS) Team (2012) Impact of HIV severity on cognitive and adaptive funtioning during childhood and adolescence. Pediatr Infect Dis J 31:592–598
Tardieu M, Mayaux MJ, Seibel N, Funck-Brentano I, Straub E, Teglas JP, Blanche S (1995) Cognitive assessment of school-age children infected with maternally transmitted human immunodeficiency virus type 1. J Pediatr 126(3):375–379
Thomas MA, Yue K, Binesh N, Davanzo P, Kumar A, Siegel B, Frye M, Curran J, Lufkin R, Martin P, Guze B (2001) Localized two-dimensional shift correlated MR spectroscopy of human brain. Magn Reson Med 46:58–67
Thomas MA, Hattori N, Umeda M, Sawada T, Naruse S (2003) Evaluation of two-dimensional L- COSY and JPRESS using a 3T MRI scanner: from phantoms to human brain in vivo. NMR Biomed 16(5):245–251
Viola A, Nicoli F, Denis B, Confort-Gouny S, Le Fur Y, Ranjeva JP, Viout P, Cozzone PJ (2004) High cerebral scyllo-inositol: a new marker of brain metabolism disturbances induced by chronic alcoholism. MAGMA 17(1):47–61
Visalli V, Muscoli C, Sacco I, Sculco F, Palma E, Costa N, Colica C, Rotiroti D, Mollace V (2007) N-acetylcysteine prevents HIV gp 120-related damage of human cultured astrocytes: correlation with glutamine synthase dysfunction. BMC Neurosci 8:106
Wang Z, Pekarskaya O, Bencheikh M, Chao W, Gelbard HA, Ghorpade A, Rothstein JD, Volsky DJ (2003) Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. Virology 312(1):60–73
Winston A, Duncombe C, Li PC, Gill JM, Kerr SJ, Puls R, Petoumenos K, Taylor-Robinson SD, Emery S, Cooper DA, Altair Study Group (2010) Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study. Clin Infect Dis 50(6):920–929
Wolters PL, Brouwers P, Moss HA, Pizzo PA (1995) Differential receptive and expressive language functioning of children with symptomatic HIV disease and relation to CT scan brain abnormalities. Pediatrics 95(1):112–119
Wright MJ, Woo E, Foley J, Ettenhofer ML, Cottingham ME, Gooding AL, Jang J, Kim MS, Castellon SA, Miller EN, Hinkin CH (2011) Antiretroviral adherence and the nature of HIV-associated verbal memory impairment. J Neuropsychiatry Clin Neurosci 23(3):324–331
Yeudall LT, Fromm D, Reddon JR, Stefanyk WO (1986) Normative data stratified by age and sex for 12 neuropsychological tests. J Clin Psychol 42(6):918–946
Young A, Yiannoutsos C, Lee E, et al (2012) Progressive changes in cerebral metabolites and effect of ART in primary HIV-1 infection: a magnetic resonance spectroscopy study. CROI 2012, 19th Conference on Retroviruses and Opportunistic Infections, Seattle, WA, Abstract 79.
Acknowledgments
The authors wish to thank Patricia Taylor for library assistance; Drs. ChrisAnna Mink and Monica Sifuentes for recruitment of control pediatric subjects at Harbor-UCLA Medical Center; Seema Kanwal, M.D., Yolanda Gonzalez, R.N., and Alma Ramirez for assistance in subject recruitment and support. Drs. Keller and Thomas acknowledge grant support from NIH NINDS (1R21NS060620-01A1).
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nagarajan, R., Sarma, M.K., Thomas, M.A. et al. Neuropsychological Function and Cerebral Metabolites in HIV-infected Youth. J Neuroimmune Pharmacol 7, 981–990 (2012). https://doi.org/10.1007/s11481-012-9407-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11481-012-9407-7